Betibeglogene Autotemcel
CAS nullBiologic
Overview
Betibeglogene autotemcel is a gene therapy used in the treatment of beta-thalassemia. It is designed to insert a functional copy of the beta-globin gene into the patient's hematopoietic stem cells to correct the underlying genetic defect.
Therapeutic areas
HematologyGenetic Disorder
Verified Supplier Partner
Do you supply Betibeglogene Autotemcel? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.